JDD Re:View: Recent Advances in Acne and Rosacea Management Dermatological practice frequently centers on the management of acne and rosacea. Although initial therapeutic strategies often appear linear, clinical challenges arise…
Read More
New Review Highlights How Dermatologists May Better Identify cSCC Patients Who Benefit From Adjuvant Radiation Have you read this article from the JDD? A new systematic review is drawing attention to…
Read More
Promising efficacy and tolerability in this small cohort of patients with treatment-resistant AD Dual Therapy for Atopic Dermatitis: Lebrikizumab and JAK Inhibitors Used in Tandem for Treatment-Resistant Cases from the…
Read More
JDD Review Examines Malassezia Folliculitis and Diagnostic Challenges for Clinicians This is a must-read article from JDD. A narrative review in the Journal of Drugs in Dermatology summarizes current evidence…
Read More
Check Out JDD Corner’s Latest Author Spotlight Our current Author Spotlight features Darrell S. Rigel MD MS, one of the co-authors of A Randomized Controlled Trial Analyzing the Likeability, Usability,…
Read More
Curated by the JDD Editors Missed any of our June highlights? June is our Acne and Rosacea issue and is packed with intriguing articles, and you’ll want to start to…
Read More
Polymeric Cleansing Technologies and Tolerability in Sensitive Skin: A JDD Review to Note Have you read this article from the JDD? A recent review examines how modern skin cleansers have…
Read More
JDD Review: Botulinum Toxin A Shows Potential for Acne Vulgaris and Acne Scarring You don’t want to miss this article in the JDD. A systematic review in the Journal of…
Read More
Guest: Dr. Kamilia Smith From hormones and metabolism to mood and menopause, corticosteroids can influence far more than the condition they're prescribed to treat. In this installment of the JDD…
Read More
Beyond the Surface: Evolving Standards in Acne Management June marks Acne Awareness Month, serving as a critical pivot point to reframe acne vulgaris not as a temporary phase, but as…
Read More
New JDD Consensus Offers Practical Guidance on Cosibelimab for Advanced cSCC Have you read this article from the JDD A recent expert consensus addresses cosibelimab, a newly FDA approved PD-L1…
Read More
Discover a smarter way to meet your continuing medical education requirements DermEdge is a free CME platform from Forefront Dermatology and MedscapeLive! designed for todays busy dermatology professionals. This on-demand…
Read More
